Advertisement
Advertisement
Laboratory Corporation of America Holdings (LH)
NYSE - Nasdaq Real Time Price. Currency in USD
Follow
At close: 04:00PM EST
After hours:
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Performance Outlook
| Previous Close | 244.50 |
| Open | 243.01 |
| Bid | 241.01 x 800 |
| Ask | 252.73 x 1000 |
| Day's Range | 242.61 - 248.03 |
| 52 Week Range | 200.32 - 290.20 |
| Volume | |
| Avg. Volume | 666,788 |
| Market Cap | 21.905B |
| Beta (5Y Monthly) | 1.05 |
| PE Ratio (TTM) | 13.17 |
| EPS (TTM) | 18.78 |
| Earnings Date | Feb 16, 2023 |
| Forward Dividend & Yield | 2.88 (1.18%) |
| Ex-Dividend Date | Feb 22, 2023 |
| 1y Target Est | 280.62 |
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Near Fair Value
-7% Est. Return
Subscribe to Yahoo Finance Plus to view Fair Value for LH
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
- Laboratory Corporation of AmeriAnalyst Report: Laboratory Corporation of America HoldingsLaboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.RatingFair ValueEconomic Moatlast monthMorningstar
- Zacks
Exact Sciences (EXAS) to Post Q4 Earnings: What's in Store?
Continued increase in Cologuard volume is likely to have benefited Exact Sciences (EXAS) Q4 performance.
- Zacks
What's in the Cards for Medtronic (MDT) in Q3 Earnings?
Severe currency headwinds are expected to have affected Medtronic's (MDT) profitability in fiscal Q3.
- Zacks
LabCorp's (LH) New Launches, Planned Spinoff to Aid Growth
In terms of portfolio enhancement, LabCorp (LH) enters into a collaboration with Becton, Dickinson and Company to advance in life-changing treatments for cancer and other diseases.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2023 Yahoo. All rights reserved.
